Cited by 207Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation MechanismsDrug-Induced Hepatotoxicity and Protection

The DOI matches its Crossref record; 41 of the 51 references it cites were found in a registry or an index.

Multiple forms of human P450 expressed in Saccharomyces cerevisiae

Imaoka, Susumu, Yamada, Takao, Hiroi, Toyoko, Hayashi, Koji, Sakaki, Toshiyuki, Yabusaki, Yoshiyasu, Funae, Yoshihiko·1996·Biochemical Pharmacology

DOI 10.1016/0006-2952(96)00052-4

Open this paper in CoChat — free account

Abstract

We systematically characterized the levels and substrate specificity of P450s from humans and rats to extrapolate drug metabolism data from experimental animals to humans. Human P450s (CYP1A2, 2A6, 2B6, 2C8, 2C9, 2C18, 2D6, 2E1, and 3A4) were expressed in Saccharomyces cerevisiae and purified. Rat P450s were purified from hepatic microsomes of rats. We investigated the catalytic activities of purified P450s in a reconstituted system. Human CYP2B6 and rat CYP2B1 had high lidocaine N-deethylation activity. Human and rat CYP2D forms had high debrisoquine 4-hydroxylation activity. Human CYP3A4 and rat CYP3A2 had high testosterone 2 beta- and 6 beta-hydroxylation activities in a modified reconstituted system with a lipid mixture. The hydroxylation site of testosterone by CYP2B6 (16 alpha- and 16 beta-positions) agreed with that by rat CYP2B1. Human CYP2E1 had the highest lauric acid (omega-1)-hydroxylation activity and also had catalytic properties similar to those of rat CYP2E1. Human CYP2A and 2C forms had catalytic properties in testosterone metabolism different from those of rats. Antibodies raised against purified P450s were used to measure the levels of hepatic P450s. The level of CYP3A4 was the highest in human hepatic microsomes, comprising 30-40% of the total P450. CYP2C9 comprised 10-20% of the total. The levels of CYP1A2, 2A6, 2C8, 2D6, and 2E1 were moderate (5-15% of total P450). CYP2B6 content was very low. The information of this study is useful for drug metabolism and toxicological studies.

Integrity signals

Registry

Crossref · 10.1016/0006-2952(96)00052-4

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.
Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P. G., Wolff, T., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89213-x · Cited by 724
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
Gonzalez, F. J., Skodat, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. (1988) · Nature · doi:10.1038/331442a0 · Cited by 715
Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene.
Ryan, D. E., Thomas, P. E., Korzeniowski, D., & Levin, W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34211-4 · Cited by 567
Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme.
Song, B., Gelboin, H. V., Park, S. S., Yang, C. S., & Gonzalez, F. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66620-7 · Cited by 405
The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
Kimura, S., Umeno, M., Skoda, R. C., Meyer, U., & Gonzalez, F. J. (1989) · Europe PMC (PubMed Central) · Cited by 404
The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes
Yamano, S., Tatsuno, J., & Gonzalez, F. J. (1990) · Biochemistry · doi:10.1021/bi00457a031 · Cited by 384
Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.
Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G., Wilkinson, G. R., & Guengerich, F. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39456-5 · Cited by 319
Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.
Hardwick, J. P., Song, B. J., Huberman, E., & Gonzalez, F. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75857-8 · Cited by 312
Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats.
Ryan, D. E., Iida, S., Wood, A. W., Thomas, P. E., Lieber, C. S., & Levin, W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43594-0 · Cited by 297

Show all 51 references

Sorted by citations

Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
Rendić, S., & Carlo, F. J. D. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709037591 · Cited by 1,165
Summary of information on human CYP enzymes: human P450 metabolism data
Rendić, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 819
Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties
Wilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794
Human Cytochrome P450 Enzymes
Guengerich, F. P. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_14 · Cited by 732
Simulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami‐Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 533
Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“CYP3A4 is the most abundant CYP expressed in the adult liver [121,122] and makes the major contribution to steroid metabolism.”
Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes
Li, J., Zhao, M., He, P., Hidalgo, M. M., & Baker, S. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0088 · Cited by 310
Dopamine Formation from Tyramine by CYP2D6
Hiroi, T., Imaoka, S., & Funae, Y. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9232 · Cited by 238
Self-citation
Roles of NADPH-P450 Reductase and Apo- and Holo-Cytochrome b5 on Xenobiotic Oxidations Catalyzed by 12 Recombinant Human Cytochrome P450s Expressed in Membranes of Escherichia coli
Yamazaki, H., Nakamura, M., Komatsu, T., Ohyama, K., Hatanaka, N., Asahi, S., Shimada, N., Guengerich, F. P., Shimada, T., Nakajima, M., et al. (2002) · Protein Expression and Purification · doi:10.1006/prep.2001.1578 · Cited by 234
Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity
Hakkola, J., Pelkonen, O., Pasanen, M., & Raunio, H. (1998) · Critical Reviews in Toxicology · doi:10.1080/10408449891344173 · Cited by 229
Human Cytochrome P450 Enzymes
Guengerich, F. P. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_10 · Cited by 226
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
Xie, H.-J., Yaşar, Ü., Lundgren, S., Griškevičius, L., Terelius, Y., Hassan, M., & Rane, A. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500157 · Cited by 215
Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis
Achour, B., Barber, J., & Rostami-Hodjegan, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058834 · Cited by 212
Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes.
Subrahmanyam, V. V., Renwick, A. B., Walters, D. G., Young, P. J., Price, R. J., Tonelli, A. P., & Lake, B. G. (2001) · PubMed · Cited by 190
Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6
Ekins, S., VandenBranden, M. R., Ring, B. J., Gillespie, J. S., Yang, T. J., Gelboin, H. V., & Wrighton, S. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37719-5 · Cited by 178
THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*
Ekins, S., & Wrighton, S. A. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101942 · Cited by 176
EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
Huang, W., Lin, Y. S., McConn, D. J., Calamia, J. C., Totah, R. A., Isoherranen, N., Glodowski, M., & Thummel, K. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001313 · Cited by 175
Involvement of CYP2J2 and CYP4F12 in the Metabolism of Ebastine in Human Intestinal Microsomes
Hashizume, T., Imaoka, S., Mise, M., Terauchi, Y., Fujii, T., Miyazaki, H., Kamataki, T., & Funae, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.298 · Cited by 159
Self-citation
A COMPARISON OF HEPATIC CYTOCHROME P450 PROTEIN EXPRESSION BETWEEN INFANCY AND POSTINFANCY
Tateishi, T., Nakura, H., Asoh, M., Watanabe, M., Tanaka, M., Kumai, T., Takashima, S., Imaoka, S., Funae, Y., Yabusaki, Y., et al. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)01011-4 · Cited by 157
Self-citation
Role of CYP2C9 polymorphism in losartan oxidation.
Yaşar, Ü., Tybring, G., Hidestrand, M., Oscarson, M., Ingelman‐Sundberg, M., Dahl, M. L., & Eliasson, E. (2001) · PubMed · Cited by 152
Functional Characterization of Cytochrome P450 2B6 Allelic Variants
Jinno, H., Tanaka‐Kagawa, T., Ohno, A., Makino, Y., Matsushima, E., Hanioka, N., & Ando, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.398 · Cited by 152
Human Cytochrome P450 Enzymes
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 159
Insights into CYP2B6-mediated drug–drug interactions
Hedrich, W. D., Hassan, H. E., & Wang, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.016 · Cited by 143
A Single Nucleotide Polymorphism of CYP2B6 Found in Japanese Enhances Catalytic Activity by Autoactivation
Ariyoshi, N., Miyazaki, M., Toide, K., Sawamura, Y.-I., & Kamataki, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4524 · Cited by 140
Development of a Comprehensive Panel of Antibodies against the Major Xenobiotic Metabolising Forms of Cytochrome P450 in Humans
Edwards, R. J., Adams, D. A., Watts, P. S., Davies, D. S., & Boobis, A. R. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00033-1 · Cited by 133
Different Contributions of Cytochrome P450 2C19 and 3A4 in the Oxidation of Omeprazole by Human Liver Microsomes: Effects of Contents of These Two Forms in Individual Human Samples
Yamazaki, H., Inoue, K., Shaw, P. M., Checovich, W. J., Guengerich, F. P., & Shimada, T. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37072-7 · Cited by 132
Applications of Nanomaterials in Electrochemical Enzyme Biosensors
Li, H., Liu, S., Dai, Z. H., Bao, J., & Yang, X. (2009) · Sensors · doi:10.3390/s91108547 · Cited by 129
CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial
Lee, A. M., Jepson, C., Hoffmann, E. B., Epstein, L. H., Hawk, L. W., Lerman, C. E., & Tyndale, R. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.005 · Cited by 131
Developmental Expression of Cytochrome P450 Enzymes in Human Liver
Hakkola, J., Tanaka, E., & Pelkonen, O. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01427.x · Cited by 128
Regioselective hydroxylation of steroid hormones by human cytochromes P450
Niwa, T., Murayama, N., Imagawa, Y., & Yamazaki, H. (2015) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1011658 · Cited by 121
Automated Definition of the Enzymology of Drug Oxidation by the Major Human Drug Metabolizing Cytochrome P450s
McGinnity, D. F., Parker, A. J., Soars, M. G., & Riley, R. J. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15081-7 · Cited by 120
Expression of Human Cytochrome P450 2B6 in Escherichia coli: Characterization of Catalytic Activity and Expression Levels in Human Liver
Hanna, I. H., Reed, J. R., Guengerich, F. P., & Hollenberg, P. F. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1708 · Cited by 112
Monospecific Antipeptide Antibody to Cytochrome P-450 2B6
Stresser, D. M., & Kupfer, D. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15215-4 · Cited by 111
The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition
Michaud, V., Bar-Magen, T., Turgeon, J., Flockhart, D. A., Desta, Z., & Wainberg, M. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005553 · Cited by 106
The GreenScreen(R) genotoxicity assay: a screening validation programme
Cahill, P. A. (2004) · Mutagenesis · doi:10.1093/mutage/geh015 · Cited by 105
Three-Dimensional Quantitative Structure Activity Relationship Analyses of Substrates for CYP2B6
Ekins, S., Bravi, G., Ring, B. J., Gillespie, T. A., Gillespie, J. S., VandenBranden, M. R., Wrighton, S. A., & Wikel, J. H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37919-4 · Cited by 104
Involvement of human liver cytochrome P4502B6in the metabolism of propofol
Oda, Y., Hamaoka, N., Hiroi, T., Imaoka, S., Hase, I., TANAKA, K. A., Funae, Y., Ishizaki, T., & Asada, A. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.00344.x · Cited by 99
Self-citation
Human hepatic CYP2B6 developmental expression: The impact of age and genotype
Croom, E. L., Stevens, J. C., Hines, R. N., Wallace, A. D., & Hodgson, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.029 · Cited by 98
Selective Phthalate Activation of Naturally Occurring Human Constitutive Androstane Receptor Splice Variants and the Pregnane X Receptor
DeKeyser, J. G., Laurenzana, E. M., Peterson, E. C., Chen, T., & Omiecinski, C. J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq394 · Cited by 98
Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics
JOHNSON, A., WANG, D., & SADEE, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.001 · Cited by 97
Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones
Niwa, T., Yabusaki, Y., Honma, K., MATSUO, N., 龍田, 佳., Ishibashi, F., & KATAGIRI, M. (1998) · Xenobiotica · doi:10.1080/004982598239290 · Cited by 97
Self-citation
Progesterone Oxidation by Cytochrome P450 2D Isoforms in the Brain
Hiroi, T., Kishimoto, W., Chow, T., Imaoka, S., Igarashi, T., & Funae, Y. (2001) · Endocrinology · doi:10.1210/endo.142.9.8363 · Cited by 94
Self-citation
Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
Sasahara, K., Shimokawa, Y., Hirao, Y., Koyama, N., Kitano, K., SHIBATA, M., & Umehara, K. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064527 · Cited by 93
Prediction ofin vivodrug clearance fromin vitrodata. II: Potential inter-ethnic differences
Inoue, S., Howgate, E. M., Rowland‐Yeo, K., Shimada, T., Yamazaki, H., Tucker, G. T., & Rostami‐Hodjegan, A. (2006) · Xenobiotica · doi:10.1080/00498250600683262 · Cited by 91
Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain
Kishimoto, W., Hiroi, T., Shiraishi, M., Osada, M., Imaoka, S., Kominami, S., Igarashi, T., & Funae, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1109 · Cited by 90
Self-citation
Reappraisal of Human CYP Isoforms Involved in Imipramine N-Demethylation and 2-Hydroxylation: A Study Using Microsomes Obtained from Putative Extensive and Poor Metabolizers of S-Mephenytoin and Eleven Recombinant Human CYPs
Koyama, E., Chiba, K., Tani, M., & Ishizaki, T. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36731-x · Cited by 84
Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver
Furukawa, M., Nishimura, M., Ogino, D., Chiba, R., Ikai, I., Ueda, N., Naito, S., Kuribayashi, S., Moustafa, M. A., Uchida, T., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03243.x · Cited by 82
Self-citation
Expression of functional mammalian P450 2E1 in hairy root cultures
Banerjee, S., Shang, T. Q., Wilson, A. M., Moore, A. L., Strand, S. E., Gordon, M. P., & Doty, S. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10151 · Cited by 82
The Decreased in Vivo Clearance of CYP2D6 Substrates by CYP2D6*10 Might Be Caused Not Only by the Low-Expression but Also by Low Affinity of CYP2D6
Fukuda, T., Nishida, Y., Imaoka, S., Hiroi, T., Naohara, M., Funae, Y., & Azuma, J. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1936 · Cited by 82
Self-citation
Di(2-ethylhexyl) phthalate Is a Highly Potent Agonist for the Human Constitutive Androstane Receptor Splice Variant CAR2
DeKeyser, J. G., Stagliano, M. C., Auerbach, S. S., Prabhu, K. S., Jones, A. D., & Omiecinski, C. J. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053702 · Cited by 81
Catalytic Specificity of CYP2D Isoforms in Rat and Human
Hiroi, T., Chow, T., Imaoka, S., & Funae, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.9.970 · Cited by 77
Self-citation
Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions
Stringer, R. A., Strain-Damerell, C. M., Nicklin, P. L., & Houston, J. B. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024810 · Cited by 76
Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments
Komatsu, K., Ito, K., Nakajima, Y., Kanamitsu, S.-I., Imaoka, S., Funae, Y., Green, C. E., Tyson, C. A., Shimada, N., & Sugiyama, Y. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15066-0 · Cited by 74
Self-citation
Metabolism and Interaction of Bisphenol A in Human Hepatic Cytochrome P450 and Steroidogenic CYP17.
Niwa, T., Fujimoto, M., Kishimoto, K., Yabusaki, Y., Ishibashi, F., & Katagiri, M. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.1064 · Cited by 74
Self-citation
Electrochemistry of cytochrome P450 enzyme on nanoparticle-containing membrane-coated electrode and its applications for drug sensing
Liu, S., Peng, L., Yang, X., Wu, Y., & He, L. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.12.001 · Cited by 72
CYP2D in the Brain
Funae, Y., Kishimoto, W., Cho, T., Niwa, T., & Hiroi, T. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.337 · Cited by 70
Self-citation
Enhancement of Cytochrome P-450 3A4 Catalytic Activities by Cytochrome b5 in Bacterial Membranes
Yamazaki, H., Nakajima, M., Nakamura, M., Asahi, S., Shimada, N., Gillam, E. M. J., Guengerich, F. P., Shimada, T., & Yokoi, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15017-9 · Cited by 69
CYP4B1 Is a Possible Risk Factor for Bladder Cancer in Humans
Imaoka, S., Yoneda, Y., Sugimoto, T., Hiroi, T., Yamamoto, K., Nakatani, T., & Funae, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3740 · Cited by 68
Self-citation
Metabolism of Sesamin by Cytochrome P450 in Human Liver Microsomes
Yasuda, K., Ikushiro, S., Kamakura, M., Ohta, M., & Sakaki, T. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035659 · Cited by 67
Self-citation
Cytochrome P450s in the development of target-based anticancer drugs
Purnapatre, K. P., Khattar, S. K., & Saini, K. S. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.024 · Cited by 64
An Investigation of the Bioactivation Potential and Metabolism Profile of Zebrafish versus Human
Chng, H. T., Ho, H. K., Yap, C. W., Lam, S. H., & Chan, E. C. Y. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112447305 · Cited by 62
Substrate-Dependent Effect of Acetonitrile on Human Liver Microsomal Cytochrome P450 2C9 (CYP2C9) Activity
Tang, C., Shou, M., & Rodrigues, A. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15101-x · Cited by 61
Involvement of cytochrome P450 2E1 in the (ω–1)-hydroxylation of oleic acid in human and rat liver microsomes
Adas, F., Berthou, F., PICART, D., Lozac'h, P., Beaugé, F. J., & Amet, Y. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32545-1 · Cited by 58
Expression of Four Rat CYP2D Isoforms inSaccharomyces cerevisiaeand Their Catalytic Specificity
Wan, J., Imaoka, S., Chow, T., Hiroi, T., Yabusaki, Y., & Funae, Y. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0402 · Cited by 57
Self-citation
Acetaldehyde as Well as Ethanol Is Metabolized by Human CYP2E1
Kunitoh, S., Imaoka, S., Hiroi, T., Yabusaki, Y., Monna, T., & Funae, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36455-9 · Cited by 55
Self-citation
Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes
Rendić, S., Nolteernsting, E., & Schänzer, W. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(99)00400-4 · Cited by 54
Expression of Cytochrome P450 2A6 in Escherichia coli: Purification, Spectral and Catalytic Characterization, and Preparation of Polyclonal Antibodies
Souček, P. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1388 · Cited by 53
Biodegradation of polychlorinated dibenzo-p-dioxins by recombinant yeast expressing rat CYP1A subfamily
Sakaki, T., Shinkyo, R., Takita, T., Ohta, M., & Inouye, K. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00036-x · Cited by 52
Self-citation
Metabolic pathways of dioxin by CYP1A1: species difference between rat and human CYP1A subfamily in the metabolism of dioxins
Shinkyo, R., Sakaki, T., Ohta, M., & Inouye, K. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00366-1 · Cited by 49
Self-citation
Inhibitory Monoclonal Antibody to Human Cytochrome P450 2B6
Yang, T. J., Krausz, K. W., Shou, M., Yang, S. K., Buters, J., Gonzalez, F. J., & Gelboin, H. V. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00018-5 · Cited by 49
Metabolism of Polychlorinated Dibenzo-p-dioxins (PCDDs) by Human Cytochrome P450-Dependent Monooxygenase Systems
Inouye, K., Shinkyo, R., Takita, T., Ohta, M., & Sakaki, T. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020415z · Cited by 48
Self-citation
Epoxyeicosatrienoic Acids and/or Their Metabolites Promote Hypoxic Response of Cells
Suzuki, S., Oguro, A., Osada‐Oka, M., Funae, Y., & Imaoka, S. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08122fp · Cited by 49
Self-citation
Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6
Niwa, T., Hiroi, T., Tsuzuki, D., Yamamoto, S., Narimatsu, S., Fukuda, T., Azuma, J., & Funae, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.030 · Cited by 45
Self-citation
Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine
Niwa, T. (1999) · Xenobiotica · doi:10.1080/004982599238731 · Cited by 46
Mammalian Cytochrome P450-Dependent Metabolism of Polychlorinated Dibenzo-p-dioxins and Coplanar Polychlorinated Biphenyls
Inui, H., Itoh, T., Yamamoto, K., Ikushiro, S., & Sakaki, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150814044 · Cited by 45
Self-citation
Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications
Zhang, Y., & Yang, L. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902967648 · Cited by 44
Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes – a comparative study
Geier, M., Braun, A., Emmerstorfer‐Augustin, A., Pichler, H., & Glieder, A. (2012) · Biotechnology Journal · doi:10.1002/biot.201200187 · Cited by 44
A Transgenic Mouse Expressing Human CYP4B1 in the Liver
Imaoka, S., Hayashi, K., Hiroi, T., Yabusaki, Y., Kamataki, T., & Funae, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5055 · Cited by 43
Self-citation
Enzymatic properties of human CYP2W1 expressed in Escherichia coli
Yoshioka, H., Kasai, N., Ikushiro, S., Shinkyo, R., Kamakura, M., Ohta, M., Inouye, K., & Sakaki, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.080 · Cited by 42
Self-citation
Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells
Lo, R., Burgoon, L. D., MacPherson, L., Ahmed, S., & Matthews, J. B. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.01.005 · Cited by 42
Variability in Aflatoxin B1–Macromolecular Binding and Relationship to Biotransformation Enzyme Expression in Human Prenatal and Adult Liver
Doi, A. M., Patterson, P. E., & Gallagher, E. P. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9399 · Cited by 41
Structure-Function Analysis of Human Cytochrome P-450 2B6 Using a Novel Substrate, Site-Directed Mutagenesis, and Molecular Modeling
Domanski, T. L., Schultz, K. M., Roussel, F., Stevens, J. C., & Halpert, J. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35016-5 · Cited by 41
Effect of Psychotropic Drugs on the 21-Hydroxylation of Neurosteroids, Progesterone and Allopregnanolone, Catalyzed by Rat CYP2D4 and Human CYP2D6 in the Brain
Niwa, T., Okada, K., Hiroi, T., Imaoka, S., Narimatsu, S., & Funae, Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.348 · Cited by 40
Self-citation
New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen
Stiborová, M., Bořek-Dohalská, L., Hodek, P., Mráz, J., & Frei, E. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00259-x · Cited by 38
CYP2M1: Cloning, Sequencing, and Expression of a New Cytochrome P450 from Rainbow Trout Liver with Fatty Acid (ω-6)-Hydroxylation Activity
Yang, Y., Wang, J.-L., Miranda, C. L., & Buhler, D. R. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0607 · Cited by 38
cDNA-directed expression of a functional zebrafish CYP1A in yeast
Chung, W., Şen, A., Wang‐Buhler, J., Yang, Y., Lopez, N. I., Merrill, G. F., Miranda, C. L., Hu, C., & Buhler, D. R. (2004) · Aquatic Toxicology · doi:10.1016/j.aquatox.2004.07.007 · Cited by 35
Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A
Adas, F., Berthou, F., Salaün, J., Dréano, Y., & Amet, Y. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00140-x · Cited by 34
Analysis of gene and protein expression of cytochrome P450 and stress‐associated molecules in rat liver after spaceflight
Baba, T., Nishimura, M., Kuwahara, Y., Ueda, N., Naitoh, S., Kume, M., Yamamoto, Y., Fujita, J., Funae, Y., & Fukumoto, M. (2008) · Pathology International · doi:10.1111/j.1440-1827.2008.02275.x · Cited by 33
Self-citation
Electrochemistry of Cytochrome P450 2B6 on Electrodes Modified with Zirconium Dioxide Nanoparticles and Platin Components
Peng, L., Yang, X., Zhang, Q., & Liu, S. (2008) · Electroanalysis · doi:10.1002/elan.200704083 · Cited by 33
CYP2B6*6 is associated with increased breast cancer risk
Justenhoven, C., Pentimalli, D., Rabstein, S., Harth, V., Lotz, A., Pesch, B., Brüning, T., Dörk, T., Schürmann, P., Bogdanova, N. V., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28356 · Cited by 33
Identification of Human Cytochrome P-450 Isoforms Involved in Metabolism of R(+)- and S(−)-Gallopamil: Utility of In Vitro Disappearance Rate
Suzuki, A., Iida, I., Tanaka, F., Akimoto, M., Fukushima, K., Tani, M., Ishizaki, T., & Chiba, K. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14926-4 · Cited by 33
Coexpression of Genetically Engineered Fused Enzyme between Yeast NADPH–P450 Reductase and Human Cytochrome P450 3A4 and Human Cytochrome b5 in Yeast
Hayashi, K., Sakaki, T., Kominami, S. A. J., Inouye, K., & Yabusaki, Y. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1953 · Cited by 31
Self-citation
Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions
Lee, M. D., Ayanoĝlu, E., & Gong, L. (2006) · Xenobiotica · doi:10.1080/00498250600861785 · Cited by 31
Improvement in the expression of CYP2B6 by co-expression with molecular chaperones GroES/EL in Escherichia coli
Mitsuda, M., & Iwasaki, M. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.10.017 · Cited by 31
Expression of drug-metabolizing enzymes
Guengerich, F. P., & Parikh, A. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80039-0 · Cited by 30
Key Learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 Rodent Uterotrophic and Hershberger Assays
Marty, M. S., & O’Connor, J. C. (2014) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.21098 · Cited by 29
Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues
Puccinelli, E., Gervasi, P. G., Marca, M. L., Beffy, P., & Longo, V. G. (2010) · Xenobiotica · doi:10.3109/00498254.2010.489125 · Cited by 29
Overexpression of CYP3A4, but not of CYP2D6, Promotes Hypoxic Response and Cell Growth of Hep3B Cells
Oguro, A., Sakamoto, K., Funae, Y., & Imaoka, S. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-rg-017 · Cited by 29
Self-citation
Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies
Niwa, T., Okamoto, A., Narita, K., Toyota, M., Kato, K., Kobayashi, K., & Sasaki, S. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108283 · Cited by 28
Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450
Niwa, T., Morimoto, M., Hirai, T., Hata, T., Hayashi, M., & Imagawa, Y. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.143 · Cited by 28

Authors: Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y., & Funae, Y.
Affiliations: Osaka City University (JP)
Sumitomo Chemical (Japan) (JP)
Corresponding author: Imaoka, Susumu
ORCID: Imaoka, Susumu
Sakaki, Toshiyuki
Venue: Biochemical Pharmacology
Publisher: Elsevier BV
Published: 1996-04
Volume: 51
Issue: 8
Pages: 1041-1050
ISSN: 0006-2952 (ISSN-L)
DOI: 10.1016/0006-2952(96)00052-4
OpenAlex: W37725492
Cited by: 207
References: 51
Citations by year: 2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 7 · 2014: 7 · 2013: 2 · 2012: 8
FWCI: 12.18
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biochemical Pharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Keywords: cytochrome P450, CYP3A4, CYP2B6, CYP2D6, CYP2E1, CYP2C9, CYP2A6, CYP2C8, CYP1A2, CYP2B1, CYP3A2, CYP2C
MeSH terms: Animals, Antibodies, Base Sequence, Cytochrome P-450 Enzyme System, Humans, Immunoassay, Isoenzymes, Microsomes, Liver, Molecular Sequence Data, Recombinant Proteins, Saccharomyces cerevisiae, Species Specificity, Substrate Specificity, Immunoblotting, Gene Expression, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple forms of human P450 expressed in Saccharomyces cerevisiae

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks